The skin hyperpigmentation index: An objective method of measuring the intensity of hyperpigmentation after sclerotherapy.

Hyperpigmentation sclerotherapy skin hyperpigmentation index

Journal

Phlebology
ISSN: 1758-1125
Titre abrégé: Phlebology
Pays: England
ID NLM: 9012921

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 28 7 2020
medline: 24 8 2021
entrez: 28 7 2020
Statut: ppublish

Résumé

Skin hyperpigmentation in chronic venous insufficiency and as a side effect in vein treatments are of great importance for the affected individuals. There are only a few qualitatively limited methods that allow its quantification. Previous techniques to develop a reliable scientific approach to quantification have failed due to the lack of standardized conditions including differences in lighting, distances and equipment. A newly developed measuring method, the "skin hyperpigmentation index", enables a fully automated and standardized quantification of skin hyperpigmentation with dermatoscopic images. The skin hyperpigmentation index defines the ratio of two scores, namely hyperpigmented skin of the affected area and normal sun protected skin from the same patient. This results in a range from 1 (no pigmentation) to 4 (maximum pigmentation). For a practical evaluation of the score, a free skin hyperpigmentation index calculator can be used online, which is accessible to all practitioners (https://shi.skinimageanalysis.com/). The skin hyperpigmentation index is a fully automated method for the quantitative assessment of skin pigmentation which can easily be applied to any skin type with any type of hyperpigmentation. This allows a simple, fast, and standardized quantification of skin hyperpigmentation and is useful for monitoring the progress and planning of whitening therapy.

Identifiants

pubmed: 32715908
doi: 10.1177/0268355520941359
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

833-835

Auteurs

Simon Bossart (S)

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Torsten Willenberg (T)

Gefässzentrum Bern, VASC, Lindehofspital Bern, Switzerland.

Albert-Adrien Ramelet (AA)

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Simone Cazzaniga (S)

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Centro Studi GISED, Bergamo, Italy.

Robert E Hunger (RE)

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Switzerland.

S Morteza Seyed Jafari (SM)

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH